Drug Trial Radar · NCT01302054
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
Last checked: Nov 20, 2026Latest source record: Dec 4, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
990
Actual
Start
May 2011
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Feb 23, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Patients with overactive bladder are often treated with tolterodine, a medication that helps relax the bladder, helping symptoms of urinary incontinence and urinary frequency. Sometimes patients do not have a satisfactory response, and may benefit from trying an alternative oral medicine. Fesoterodine is related to tolterodine by producing the same active substance that acts on the bladder, but potentially at higher and more effective levels. So, a patient who has a poor response to tolterodine may still obtain a good response to fesoterodine. This study will help find out if this is what happens.
Conditions
- Urinary Bladder, Overactive
Interventions
Fesoterodine 8 mgDrug
Fesoterodine sustained release tablets once every morning at 4 mg dose for first week, followed by 11 weeks at 8 mg strength.
PlaceboDrug
Matching placebo for fesoterodine 4 and 8 mg for a total of 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Number of Urgency Urinary Incontinence (UUI) Episodes Per 24 HoursTime frame: Baseline, Week 12
- Change From Baseline in Mean Number of Urgency Urinary Incontinence (UUI) Episodes Per 24 Hours at Week 12Time frame: Baseline, Week 12
Locations
176 sites in 15 countries. Site status is shown where the registry gives one.
Radiant Research, Inc.
Birmingham, Alabama
Alabama Internal Medicine, PC
Birmingham, Alabama
Brown and McCool Gynecology
Fairhope, Alabama
Radiant Research, Inc.
Chandler, Arizona
Eclipse Clinical Research
Green Valley, Arizona
Radiant Research, Inc.
Tucson, Arizona
Urological Associates of Southern Arizona, PC
Tucson, Arizona
American Institute of Research
Los Angeles, California
Moaz Khorsandi, DO
Los Angeles, California
Urology Group of Southern California
Los Angeles, California
Institute for Advanced Urology
Los Angeles, California
Center for Clinical Trials, LLC
Paramount, California
Sierra Clinical Research
Roseville, California
Superior Research LLC
Sacramento, California
California Research Foundation
San Diego, California
Medical Center for Clinical Research
San Diego, California
Advanced Urology, PC
Parker, Colorado
Thameside Obstetrics/Gynecological Center
Groton, Connecticut
S.H.E. Medical Associates
Hartford, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut
Manatee Medical Research Institute, LLC
Bradenton, Florida
Atlantic Institute of Clinical Research
Daytona Beach, Florida
SJS Clinical Research
Destin, Florida
Ocala Urology Specialists
Ocala, Florida
Renstar Medical Research, Inc.
Ocala, Florida
Accord Clinical Research, LLC
Port Orange, Florida
Pinellas Urology, Inc.
St. Petersburg, Florida
Florida Urology Partners
Tampa, Florida
The Office of Georgis Patsias, MD, PA
Wellington, Florida
Palm Beach Research Center
West Palm Beach, Florida
Atlanta Medical Research Institute, LLC
Alpharetta, Georgia
Radiant Research, Inc.
Atlanta, Georgia
In-Quest Medical Research, LLC
Duluth, Georgia
Prism Research Group
Rome, Georgia
Valley Health Care
Rome, Georgia
Fox Valley Clinical Research Center, LLC
Aurora, Illinois
Radiant Research, Inc.
Chicago, Illinois
Urology of Indiana, LLC
Noblesville, Indiana
Radiant Research, Inc.
Overland Park, Kansas
Regional Urology, LLC
Shreveport, Louisiana
Showing 40 of 176 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.